Kim Tipton

Senior Clinical Scientist at ALX Oncology

Kim Tipton is a Senior Clinical Scientist at ALX Oncology since May 2023, leading phase 2 clinical science initiatives for HNSCC and contributing to solid tumor clinical trials involving evorpacept. Previously, Kim served as Director of Clinical Science at CRISPR Therapeutics, overseeing allogeneic CAR T cell therapies, and held various roles including Associate Director of Clinical Development focused on CD70-directed CAR T therapy. Prior experience includes directing biologics discovery at pH Pharma Inc., leading significant projects at CytomX Therapeutics, and research positions at Catalyst Biosciences and UC Berkeley. Kim holds a PhD in Cellular and Molecular Biology from the University of California, San Francisco, along with a BS in Microbiology and a BA in English Literature from The University of Texas at Austin.

Links

Previous companies

CRISPR Therapeutics logo
UC Berkeley logo
Catalyst Biosciences logo
CytomX logo
Adimab logo

Org chart

Sign up to view 0 direct reports

Get started



Offices

This person is not in any offices